Skip to main content
Tech.euFundingExplorerBeta

Paradigm BioCapital Advisors

Investor profile

Venture capital

Paradigm BioCapital Advisors has backed 1 European tech company across 1 funding round in 2023, joining rounds totalling €261M. Most active in Healthtech. Data as of 4 Nov 2026.

Deals
1
distinct rounds
Companies
1
backed
Active span
2023
1 yr
Total round €
€261M
sum of rounds joined

Deals by year

distinct rounds / year
Paradigm BioCapital Advisors — deals by year — interactive chart.
Data table
Paradigm BioCapital Advisors — deals by year
20231

Top sectors

by deals
Paradigm BioCapital Advisors — top sectors — interactive chart.
Data table
Paradigm BioCapital Advisors — top sectors
Healthtech1

Stages

by deals
Paradigm BioCapital Advisors — stages — interactive chart.
Data table
Paradigm BioCapital Advisors — stages
Other1

Countries

by deals
Paradigm BioCapital Advisors — countries — interactive chart.
Data table
Paradigm BioCapital Advisors — countries
UK1

Co-investment network

shared rounds
Co-investment network — interactive chart.
Paradigm BioCapital Advisors — 1 dealsParadigm BioCapital AdvisorsAisling Capital — 1 shared deals · click to openAisling CapitalArmistice Capital — 1 shared deals · click to openArmistice CapitalLaurion Capital Management — 1 shared deals · click to openLaurion Capital ManagementLogos Capital — 1 shared deals · click to openLogos CapitalPFM Health Sciences — 1 shared deals · click to openPFM Health SciencesRA Capital — 1 shared deals · click to openRA CapitalSoleus Capital — 1 shared deals · click to openSoleus CapitalSurveyor Capital — 1 shared deals · click to openSurveyor CapitalTCG X — 1 shared deals · click to openTCG XVivo Capital — 1 shared deals · click to openVivo Capital

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
Compass PathwaysUK1€261M

Biggest deals

top 10 by amount
CompanyStageAmountDate
Compass PathwaysOther€261M2023-08
← Back to investors